1-3 of 3
Mark S. Hertzberg, MBBS, PhD, FRACP
Close
Sort by
Journal Articles

A Novel Anti-Lymphoma Immune Evasion Mediated By the Interaction Between PD-1 Enriched NK-Cells and CD163+PD-L1+PD-L2+ Tumor Associated Macrophages, That Is More Prominent in Hodgkin Lymphoma Than Diffuse Large B-Cell Lymphoma

Maher K Gandhi, PhDFRACP FRCPath FRCP, David Arpon, Colm Keane, Erica Han, Josh Tobin, MD, Robert Bird, FRACP, FRCP, FRCPA, MBBS, MRCP, Mark S Hertzberg, MBBS PhD FRACP FRCPA, Marlene Self, Donna Cross, Annette Hernandez, BS, Frank Vari, PhD
Journal: Blood
Blood (2016) 128 (22): 918.
https://doi.org/10.1182/blood.V128.22.918.918
Published: 2016
Journal Articles

Utility Of Non-Invasive Monitoring Of Circulating Tumor DNA At Diagnosis, Interim Therapy, and Relapse Of DLBCL Using High-Throughput Sequencing Of Immunoglobulin Genes

Michael R Green, PH.D., Scott Bratman, M.D., Chih Long Liu, Ph.D., Kazuhiro Takahashi, Cynthia Glover, Colm Keane, MB BCh BAO MSc MRCPI FRCPath, Shingo Kihira, Katie Kong, Malek Faham, MD, PhD, Corbelli Karen, David B. Miklos, MD, PhD, Ranjana H. Advani, MD, Ronald Levy, MD, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Maher K Gandhi, Maximilian Diehn, Ash A. Alizadeh, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4264.
https://doi.org/10.1182/blood.V122.21.4264.4264
Published: 2013
Journal Articles

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

Jeffrey E Lancet, MD, Andrew H Wei, MBBS, PhD, Simon TS Durrant, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Ian D Lewis, MB, BS, PhD, Brian Jonas, MD, PhD, Jorge E. Cortes, MD, Geoffrey Yarranton, PhD, Jackie M. Walling, MBChB, PhD
Journal: Blood
Blood (2013) 122 (21): 3838.
https://doi.org/10.1182/blood.V122.21.3838.3838
Published: 2013